In this episode, Marc and Mo highlight 2 recent JBJS and OrthoEvidence articles that caught their eye: (1) a propensity-matched study focusing on complete and pending fractures in patients with long-bone metastases and (2) an Advanced Clinical Evidence report focusing on the WHiTE-5 trial comparing cemented vs. uncemented hemiarthroplasty for intracapsular hip fracture. OrthoJOE Mailbag: feedback, comments, and suggestions from our audience can be sent to orthojoe@jbjs.org Links: • Groot OQ, Lans A, Twining PK, Bongers MER, Kapoor ND, Verlaan JJ, Newman ET, Raskin KA, Lozano-Calderon SA, Janssen SJ, Schwab JH. Clinical Outcome Differences in the Treatment of Impending Versus Completed Pathological Long-Bone Fractures. J Bone Joint Surg Am. 2022 Feb 16;104(4):307-315. doi: 10.2106/JBJS.21.00711. PMID: 34851323. • The WHiTE 5 Trial: Cemented vs. Uncemented Hemiarthroplasty for Intracapsular Hip Fracture. ACE Report. 2022;191(1):2. Available from: https://myorthoevidence.com/AceReport/Report/14311 Keywords: Orthopaedics, JBJS, OrthoEvidence, complete fracture, impending fracture, propensity-score matching, IM nailing, irradiation, cement, hemiarthroplasty, intracapsular hip fracture, WHiTE 5 Trial, arthroplasty, mortality, reoperation, implant failure